Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Chenodeoxycholic acid
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Chenodeoxycholic acid 250mg capsules
0109010G0AAABAB
|
Chenodeoxycholic acid | Chenodeoxycholic acid | Gastro-Intestinal System | 1 |
|
Chenodeoxycholic acid 200mg tablets
0109010G0AAAPAP
|
Chenodeoxycholic acid | Chenodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Chenodeoxycholic acid 250mg tablets
0109010G0AAACAC
|
Chenodeoxycholic acid | Chenodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Chenodiol 250mg tablets
0109010G0BGAAAC
|
Chenodiol | Chenodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Xenbilox 250mg capsules
0109010G0BHAAAB
|
Xenbilox | Chenodeoxycholic acid | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.